{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T03:20:39Z","timestamp":1794626439837,"version":"4.9.1"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T00:00:00Z","timestamp":1770768000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004325","name":"AstraZeneca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004325","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100030833","name":"Syneos Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100030833","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.vaccine.2026.128345","type":"journal-article","created":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T09:52:23Z","timestamp":1772617943000},"page":"128345","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["A Phase IIa randomized clinical trial of a respiratory syncytial virus and human metapneumovirus combination protein-based virus-like particle vaccine in adults 60\u201385\u00a0years of age"],"prefix":"10.1016","volume":"77","author":[{"given":"Matthew","family":"Davis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Craig","family":"Shapiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Max","family":"Ciarlet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth M.","family":"Adams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas","family":"Hourguettes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"April E.","family":"Engram","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judy","family":"Wen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Himanshu","family":"Bansal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathryn","family":"Shoemaker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wasima","family":"Rida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anastasia A.","family":"Aksyuk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Price","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tope","family":"Oyedele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lee-Jah","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niranjan","family":"Kanesa-thasan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2026.128345_bb0005","doi-asserted-by":"crossref","first-page":"2912","DOI":"10.1099\/jgv.0.000959","article-title":"ICTV virus taxonomy profile: Pneumoviridae","volume":"98","author":"Rima","year":"2017","journal-title":"J Gen Virol"},{"key":"10.1016\/j.vaccine.2026.128345_bb0010","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1038\/89098","article-title":"A newly discovered human pneumovirus isolated from young children with respiratory tract disease","volume":"7","author":"van den Hoogen","year":"2001","journal-title":"Nat Med"},{"key":"10.1016\/j.vaccine.2026.128345_bb0015","doi-asserted-by":"crossref","first-page":"182","DOI":"10.15585\/mmwr.mm7411a1","article-title":"Human metapneumovirus seasonality and co-circulation with respiratory syncytial virus - United States, 2014-2024","volume":"74","author":"Jobe","year":"2025","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.vaccine.2026.128345_bb0020","doi-asserted-by":"crossref","first-page":"ofab491","DOI":"10.1093\/ofid\/ofab491","volume":"8","author":"Falsey","year":"2021","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.vaccine.2026.128345_bb0025","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1093\/infdis\/jit839","article-title":"Respiratory syncytial virus and other respiratory viral infections in older adults with moderate to severe influenza-like illness","volume":"209","author":"Falsey","year":"2014","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2026.128345_bb0030","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1186\/s12879-015-1218-z","article-title":"Modelling estimates of the burden of respiratory syncytial virus infection in adults and the elderly in the United Kingdom","volume":"15","author":"Fleming","year":"2015","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.vaccine.2026.128345_bb0035","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1093\/cid\/ciab595","article-title":"Incidence of respiratory syncytial virus infection among hospitalized adults, 2017-2020","volume":"74","author":"Branche","year":"2022","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2026.128345_bb0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.lanhl.2024.100679","article-title":"The global burden of human metapneumovirus-associated acute respiratory infections in older adults: a systematic review and meta-analysis","volume":"6","author":"Kulkarni","year":"2025","journal-title":"Lancet Healthy Longev"},{"key":"10.1016\/j.vaccine.2026.128345_bb0045","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofae631.880","article-title":"P-684. Wheezing, fever, snot, oh my! Comparing respiratory syncytial virus (RSV) and human metapneumovirus (HMPV) in adults: implications for vaccine development","volume":"12","author":"Samoriski","year":"2025","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.vaccine.2026.128345_bb0050","doi-asserted-by":"crossref","first-page":"4121","DOI":"10.1016\/j.vaccine.2022.05.077","article-title":"Estimating the burden of adult hospitalized RSV infection including special populations","volume":"40","author":"Nowalk","year":"2022","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2026.128345_bb0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.cmi.2020.04.005","article-title":"Characteristics of human metapneumovirus infection in adults hospitalized for community-acquired influenza-like illness in France, 2012-2018: a retrospective observational study","volume":"27","author":"Loubet","year":"2021","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.vaccine.2026.128345_bb0060","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s13613-023-01117-w","article-title":"Clinical significance of human metapneumovirus detection in critically ill adults with lower respiratory tract infections","volume":"13","author":"Kapandji","year":"2023","journal-title":"Ann Intensive Care"},{"key":"10.1016\/j.vaccine.2026.128345_bb0065","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.cmi.2024.10.023","article-title":"Epidemiology of human metapneumovirus among children with severe or very severe pneumonia in high pneumonia burden settings: the Pneumonia Etiology Research for Child Health (PERCH) study experience","volume":"31","author":"Miyakawa","year":"2025","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.vaccine.2026.128345_bb0070","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2024.1435294","article-title":"Changes in the epidemiological patterns of respiratory syncytial virus and human metapneumovirus infection among pediatric patients and their correlation with severe cases: a long-term retrospective study","volume":"14","author":"Kuang","year":"2024","journal-title":"Front Cell Infect Microbiol"},{"key":"10.1016\/j.vaccine.2026.128345_bb0075","article-title":"Global burden of lower respiratory infections and aetiologies, 1990-2023: a systematic analysis for the global burden of disease study 2023","year":"2025","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2026.128345_bb0080","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aac4241","article-title":"Prefusion F-specific antibodies determine the magnitude of RSV neutralizing activity in human sera","volume":"7","author":"Ngwuta","year":"2015","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.vaccine.2026.128345_bb0085","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1093\/infdis\/163.4.693","article-title":"Immunity to and frequency of reinfection with respiratory syncytial virus","volume":"163","author":"Hall","year":"1991","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2026.128345_bb0090","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1099\/vir.0.82663-0","article-title":"Experimental infection of macaques with human metapneumovirus induces transient protective immunity","volume":"88","author":"van den Hoogen","year":"2007","journal-title":"J Gen Virol"},{"key":"10.1016\/j.vaccine.2026.128345_bb0095","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1016\/j.vaccine.2009.11.063","article-title":"Humoral immunity to human metapneumovirus infection in adults","volume":"28","author":"Falsey","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2026.128345_bb0100","unstructured":"US Food and Drug Administration (FDA). AREXVY (Respiratory Syncytial Virus Vaccine, Adjuvanted) Prescribing Information. Updated August 2025. Available at: https:\/\/www.fda.gov\/media\/167805\/download. Last accessed 7 October 2025."},{"key":"10.1016\/j.vaccine.2026.128345_bb0105","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1093\/cid\/ciae010","article-title":"Efficacy and safety of respiratory syncytial virus (RSV) prefusion F protein vaccine (RSVPreF3 OA) in older adults over 2 RSV seasons","volume":"78","author":"Ison","year":"2024","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2026.128345_bb0110","unstructured":"US Food and Drug Administration (FDA). ABRYSVO\u00ae (Respiratory Syncytial Virus Vaccine) Prescribing Information. Updated July 2025. Available at: https:\/\/www.fda.gov\/media\/168889\/download. Last accessed 7 October 2025."},{"key":"10.1016\/j.vaccine.2026.128345_bb0115","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1056\/NEJMoa2213836","article-title":"Efficacy and safety of a bivalent RSV prefusion F vaccine in older adults","volume":"388","author":"Walsh","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2026.128345_bb0120","unstructured":"US Food and Drug Administration (FDA). MRESVIA (Respiratory Syncytial Virus Vaccine) Prescribing Information. Updated June 2025. Available at: https:\/\/www.fda.gov\/media\/179005\/download. Last accessed 7 October 2025."},{"key":"10.1016\/j.vaccine.2026.128345_bb0125","doi-asserted-by":"crossref","first-page":"2233","DOI":"10.1056\/NEJMoa2307079","article-title":"Efficacy and safety of an mRNA-based RSV PreF vaccine in older adults","volume":"389","author":"Wilson","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2026.128345_bb0130","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1080\/14760584.2025.2508517","article-title":"Virus-like particles: a versatile and effective vaccine platform","volume":"24","author":"Bachmann","year":"2025","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.vaccine.2026.128345_bb0135","series-title":"PREHEVBRIO [Hepatitis B Vaccine (Recombinant)] Prescribing Information","author":"US Food and Drug Administration (FDA)","year":"2025"},{"key":"10.1016\/j.vaccine.2026.128345_bb0140","series-title":"CERVARIX [Human Papillomavirus Bivalent (Types 16 and 18) Vaccine, Recombinant] Prescribing Information","author":"US Food and Drug Administration (FDA)","year":"2025"},{"key":"10.1016\/j.vaccine.2026.128345_bb0145","series-title":"GARDASIL\u00ae9 (Human Papillomavirus 9-valent Vaccine, Recombinant) Prescribing Information","author":"US Food and Drug Administration (FDA)","year":"2025"},{"key":"10.1016\/j.vaccine.2026.128345_bb0150","series-title":"GARDASIL\u00ae [Human Papillomavirus Quadrivalent (Types 6, 11, 16, and 18) Vaccine, Recombinant] Prescribing Information","author":"US Food and Drug Administration (FDA)","year":"2025"},{"key":"10.1016\/j.vaccine.2026.128345_bb0155","series-title":"VIMKUNYA (Chikungunya Vaccine, Recombinant) Prescribing Information","author":"US Food and Drug Administration (FDA)","year":"2025"},{"key":"10.1016\/j.vaccine.2026.128345_bb0160","doi-asserted-by":"crossref","DOI":"10.1016\/S2214-109X(24)00092-5","article-title":"Facilitating the development of urgently required combination vaccines","volume":"12","author":"Hausdorff","year":"2024","journal-title":"Lancet Glob Health"},{"key":"10.1016\/j.vaccine.2026.128345_bb0165","series-title":"A two-component VLP vaccine platform for the development of a bivalent vaccine against RSV and hMPV. Abstract ARNI0118. Presented at the 12th International RSV Symposium (RSV2022); 29 September\u201301 October 2022; Belfast, UK","author":"Feldhaus","year":"2022"},{"key":"10.1016\/j.vaccine.2026.128345_bb0170","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofaf160","article-title":"A randomized phase 1 clinical trial of a respiratory syncytial virus and human metapneumovirus combination protein-based virus-like particle vaccine in adults 60-75 years of age","volume":"12","author":"Shapiro","year":"2025","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.vaccine.2026.128345_bb0175","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1503\/cmaj.050051","article-title":"A global clinical measure of fitness and frailty in elderly people","volume":"173","author":"Rockwood","year":"2005","journal-title":"Can Med Assoc J"},{"key":"10.1016\/j.vaccine.2026.128345_bb0180","doi-asserted-by":"crossref","first-page":"210","DOI":"10.5770\/cgj.23.463","article-title":"Using the clinical frailty scale in allocating scarce health care resources","volume":"23","author":"Rockwood","year":"2020","journal-title":"Can Geriatr J"},{"key":"10.1016\/j.vaccine.2026.128345_bb0185","doi-asserted-by":"crossref","first-page":"2056","DOI":"10.1093\/infdis\/jiab611","article-title":"Phase 1\/2 randomized study of the immunogenicity, safety, and tolerability of a respiratory syncytial virus prefusion F vaccine in adults with concomitant inactivated influenza vaccine","volume":"225","author":"Falsey","year":"2022","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2026.128345_bb0190","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1093\/infdis\/jiac327","article-title":"Safety and immunogenicity of a respiratory syncytial virus prefusion F (RSVPreF3) candidate vaccine in older adults: phase 1\/2 randomized clinical trial","volume":"227","author":"Leroux-Roels","year":"2023","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2026.128345_bb0195","doi-asserted-by":"crossref","first-page":"355","DOI":"10.15585\/mmwr.mm7214a1","article-title":"Seasonality of respiratory syncytial virus - United States, 2017-2023","volume":"72","author":"Hamid","year":"2023","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.vaccine.2026.128345_bb0200","doi-asserted-by":"crossref","DOI":"10.1016\/S2214-109X(19)30264-5","article-title":"Global patterns in monthly activity of influenza virus, respiratory syncytial virus, parainfluenza virus, and metapneumovirus: a systematic analysis","volume":"7","author":"Li","year":"2019","journal-title":"Lancet Glob Health"},{"key":"10.1016\/j.vaccine.2026.128345_bb0205","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2025.103281","article-title":"Real-world uptake of nirsevimab, RSV maternal vaccine, and RSV vaccines for older adults: a systematic review and meta-analysis","volume":"84","author":"Trusinska","year":"2025","journal-title":"EClinicalMedicine"},{"key":"10.1016\/j.vaccine.2026.128345_bb0210","doi-asserted-by":"crossref","unstructured":"Bonanni P, Heo JY, Honda H, Lee P-I, Mouliom A, Leong HN, et al. Optimal timing of vaccination: a narrative review of integrating strategies for COVID-19, influenza, and respiratory syncytial virus. Infect Dis Ther 2025;14:911\u201332.","DOI":"10.1007\/s40121-025-01135-0"},{"key":"10.1016\/j.vaccine.2026.128345_bb0215","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1056\/NEJMoa043951","article-title":"Respiratory syncytial virus infection in elderly and high-risk adults","volume":"352","author":"Falsey","year":"2005","journal-title":"N Engl J Med"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X26001532?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X26001532?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T06:25:38Z","timestamp":1776147938000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X26001532"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":43,"alternative-id":["S0264410X26001532"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2026.128345","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A Phase IIa randomized clinical trial of a respiratory syncytial virus and human metapneumovirus combination protein-based virus-like particle vaccine in adults 60\u201385\u00a0years of age","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2026.128345","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"128345"}}